The European Medicines Agency on Tuesday said it would hold an extraordinary meeting on December 29 to consider emergency approval for a vaccine developed by Germany’s BioNTech and US giant Pfizer

The European Medicines Agency on Tuesday said it would hold an extraordinary meeting on December 29 to consider emergency approval for a vaccine developed by Germany’s BioNTech and US giant Pfizer